DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,132 filers reported holding DANAHER CORPORATION in Q1 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $565,152 | -6.4% | 2,262 | -6.5% | 0.26% | -2.3% |
Q1 2024 | $603,817 | -2.5% | 2,418 | -9.7% | 0.26% | -2.2% |
Q4 2023 | $619,291 | -7.1% | 2,677 | -0.4% | 0.27% | -14.6% |
Q3 2023 | $666,885 | -8.2% | 2,688 | -11.2% | 0.31% | -3.7% |
Q2 2023 | $726,480 | +4.7% | 3,027 | +10.0% | 0.33% | +0.6% |
Q1 2023 | $693,863 | +8.2% | 2,753 | +13.9% | 0.32% | +8.0% |
Q4 2022 | $641,224 | +8.5% | 2,416 | +5.7% | 0.30% | -1.6% |
Q3 2022 | $591,000 | +3.1% | 2,285 | +1.1% | 0.30% | +12.1% |
Q2 2022 | $573,000 | -4.0% | 2,261 | +11.0% | 0.27% | +5.4% |
Q1 2022 | $597,000 | +18.2% | 2,037 | +32.7% | 0.26% | +31.6% |
Q4 2021 | $505,000 | +3266.7% | 1,535 | +2970.0% | 0.20% | +3166.7% |
Q3 2021 | $15,000 | +15.4% | 50 | 0.0% | 0.01% | +20.0% |
Q2 2021 | $13,000 | +18.2% | 50 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $11,000 | 0.0% | 50 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $11,000 | 0.0% | 50 | 0.0% | 0.01% | -16.7% |
Q3 2020 | $11,000 | +22.2% | 50 | 0.0% | 0.01% | +20.0% |
Q2 2020 | $9,000 | +28.6% | 50 | 0.0% | 0.01% | +25.0% |
Q1 2020 | $7,000 | -41.7% | 50 | -33.3% | 0.00% | -33.3% |
Q4 2019 | $12,000 | +9.1% | 75 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $11,000 | 0.0% | 75 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $11,000 | +10.0% | 75 | 0.0% | 0.01% | +20.0% |
Q1 2019 | $10,000 | +25.0% | 75 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $8,000 | 0.0% | 75 | 0.0% | 0.01% | +25.0% |
Q3 2018 | $8,000 | +14.3% | 75 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $7,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $7,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $7,000 | +16.7% | 75 | 0.0% | 0.00% | +33.3% |
Q3 2017 | $6,000 | 0.0% | 75 | 0.0% | 0.00% | -25.0% |
Q2 2017 | $6,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $6,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $6,000 | – | 75 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |